University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Dorie Apollonio, MPP, PhD

Dorie Apollonio, MPP, PhD

Assistant Adjunct Professor, Department of Clinical Pharmacy, UCSF

Cancer Center Program Memberships

Tobacco Control

Research Summary

Dr. Apollonio is Professor in the Department of Clinical Pharmacy at the University of California, San Francisco. She has served as an instructor and research mentor in the UCSF School of Pharmacy since 2004, and has earned multiple teaching awards. Her research focus is the translation of research into policy. She is particularly interested in the political and marketing activities of industries implicated in the spread of non-communicable diseases, which include tobacco, pharmaceuticals, cannabis, alcohol, and food. Her recent work addresses tobacco control in vulnerable populations, the combined use of tobacco and cannabis, the spread of laws addressing new tobacco and cannabis delivery systems, and policies that allow substitution of cannabis for opiates. Her research also considers the ways that clinical findings are used in developing policy interventions and communicating knowledge from scientists to the public, and identifies methods to increase the role of evidence in making public health policy decisions. The analysis underlying these findings relies on multiple data sources (including clinical research findings, surveillance datasets, internal industry documents, administrative datasets, and interviews) and uses both qualitative and quantitative methods to identify how policies affecting public health are made. Her work has been published in journals across disciplines, including law, medicine, pharmacy, political science, public health, and public policy. Her training includes a postdoctoral appointment at the UCSF Center for Tobacco Control Research and Education, a Ph.D. in Political Science from the University of California, Berkeley, and a Master in Public Policy from Harvard University. In 2014, she became Associate Director of US Cochrane West, a branch of the Cochrane Collaboration. She also serves on Cochrane’s Funding Advisory Panel, which identifies and addresses potential conflicts of interests among authors of systematic reviews.

Education

Macalester College, St. Paul, MN, BA, 1992, Political Science, History
Harvard Kennedy School, Cambridge, MA, MPP, 1994, Health Policy
University of California, Berkeley, CA, PhD, 2003, Political Science
University of California, San Francisco, CA, Postdoctoral, 2003-2006, Health Policy
 


Professional Experience

  • 1993
    Research Analyst and Interviewer, Seattle-King County Department of Public Health, Seattle-Area Needle Exchange and AIDS Prevention Unit
  • 1993-1994
    Graduate Student Instructor, Harvard Kennedy School
  • 1994-2002
    Graduate Student Researcher, UC Berkeley
  • 1998-2000
    Statistical Consultant, Pacific Gas & Electric Dynamic Load Profiling Group
  • 2002-2003
    Survey Research Associate, Public Policy Institute of California
  • 2003-2005
    Postdoctoral Fellow, UCSF School of Medicine
  • 2005-2006
    Postdoctoral Fellow, UCSF Schools of Pharmacy and Nursing
  • 2006-present
    Assistant Professor, UCSF School of Pharmacy

Honors & Awards

  • 1995
    Henry Robert Braden Fellowship, UC Berkeley
  • 2000-2001
    Graduate Dissertation Fellowship, UC Berkeley
  • 2003-2005
    American Legacy Foundation Fellowship, UCSF School of Medicine
  • 2005
    Certificate in Health Services Research, UCSF School of Medicine
  • 2008
    Academic Senate Travel Grant, UCSF
  • 2008
    Dean's Recognition for Excellence in Teaching Award, UCSF School of Pharmacy
  • 2009
    Regulation and Governance Prize for the best article published in the journal in 2007 or 2008

Selected Publications

  1. Huey J, Apollonio DE. A review of tobacco policies on University of California campuses. Californian Journal of Health Promotion. 2019; 1(17):24-30.
    View on PubMed
  2. Pimentel L, Apollonio DE. Placement and sales of tobacco products and nicotine replacement therapy in tobacco-free and tobacco-selling pharmacies in Northern California: an observational study. BMJ Open. 2019 Jun 14; 9(6):e025603.
    View on PubMed
  3. Apollonio DE, Glantz SA. Tobacco industry promotions and pricing after tax increases: An analysis of internal industry documents. Nicotine Tob Res. 2019 May 06.
    View on PubMed
  4. Wiltse DL, La Raja RJ, Apollonio DE. Typologies of Party Finance Systems: A Comparative Study of How Countries Regulate Party Finance and Their Institutional Foundations. Election Law Journal. 2019.
    View on PubMed
  5. Apollonio DE, Spetz J, Schmidt L, Jacobs L, Kaur M, Ramo D. Prevalence and Correlates of Simultaneous and Separate 30-Day Use of Tobacco and Cannabis: Results from the California Adult Tobacco Survey. Subst Use Misuse. 2019 Apr 11; 1-6.
    View on PubMed
  6. Vijayaraghavan M, Apollonio DE. Engaging Adults Experiencing Homelessness in Smoking Cessation Through Large-Scale Community Service Events. Health Promot Pract. 2019 May; 20(3):325-327.
    View on PubMed
  7. Apollonio DE, Broyde K, Azzam A, De Guia M, Heilman J, Brock T. Pharmacy students can improve access to quality medicines information by editing Wikipedia articles. BMC Med Educ. 2018 Nov 20; 18(1):265.
    View on PubMed
  8. Huey J, Apollonio DE. A content analysis of popular media reporting regarding increases in minimum ages of legal access for tobacco. BMC Public Health. 2018 Sep 17; 18(1):1129.
    View on PubMed
  9. Apollonio DE, Glantz SA. Marketing with tobacco pack onserts: a qualitative analysis of tobacco industry documents. Tob Control. 2018 Jun 28.
    View on PubMed
  10. Kearns C, Schmidt L, Apollonio D, Glantz S. The sugar industry's influence on policy. Science. 2018 05 04; 360(6388):501.
    View on PubMed
  11. Kearns CE, Apollonio D, Glantz SA. Sugar industry sponsorship of germ-free rodent studies linking sucrose to hyperlipidemia and cancer: An historical analysis of internal documents. PLoS Biol. 2017 Nov; 15(11):e2003460.
    View on PubMed
  12. Apollonio D, Glantz SA. Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us". Am J Public Health. 2017 10; 107(10):1636-1642.
    View on PubMed
  13. Sung H, Apollonio DE. Evaluation of Tobacco Control Policies in San Francisco Homeless Housing Programs. Health Promot Pract. 2017 07; 18(4):571-580.
    View on PubMed
  14. Apollonio DE, Bero LA. Interpretation and use of evidence in state policymaking: a qualitative analysis. BMJ Open. 2017 02 20; 7(2):e012738.
    View on PubMed
  15. Gruenberg K, Apollonio DE, MacDougall C, Brock T. Sustainable pharmacy: Piloting a brief curriculum surrounding pharmaceuticals, climate change, and sustainability within a US pharmacy program. Innovations in pharmacy. 2017; 4(8):3.
    View on PubMed
  16. Apollonio D, Philipps R, Bero L. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev. 2016 11 23; 11:CD010274.
    View on PubMed
  17. Apollonio DE, Wolfe N, Bero LA. Realist review of policy intervention studies aimed at reducing exposures to environmental hazards in the United States. BMC Public Health. 2016 08 18; 16(1):822.
    View on PubMed
  18. Apollonio DE, Bero LA. Challenges to generating evidence-informed policy and the role of systematic reviews and (perceived) conflicts of interest. J Commun Healthc. 2016; 9(2):135-141.
    View on PubMed
  19. Apollonio DE, Glantz SA. Minimum Ages of Legal Access for Tobacco in the United States From 1863 to 2015. Am J Public Health. 2016 07; 106(7):1200-7.
    View on PubMed
  20. Krauth D, Apollonio DE. Overview of state policies requiring smoking cessation therapy in psychiatric hospitals and drug abuse treatment centers. Tob Induc Dis. 2015; 13:33.
    View on PubMed

Go to UCSF Profiles, powered by CTSI